Amedeo Smart

Free Medical Literature Service

 

Amedeo

Inflammatory Bowel Diseases
  Free Subscription

29.09.2025

1 Aliment Pharmacol Ther
1 Clin Gastroenterol Hepatol
3 Dig Dis Sci
3 Gastroenterology
16 Inflamm Bowel Dis
2 J Clin Gastroenterol
10 J Crohns Colitis
1 J Gastroenterol
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Scand J Gastroenterol


    Aliment Pharmacol Ther

  1. MASSIRONI S, Zilli A, Furfaro F, Allocca M, et al
    Systematic Review: Ultrasound Goes Echo-Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound.
    Aliment Pharmacol Ther. 2025 Sep 23. doi: 10.1111/apt.70385.
    >> Share


    Clin Gastroenterol Hepatol

  2. LOVETT GC, Schulberg JD, Hamilton A, Wright EK, et al
    Long-term Results of Drug Treatment for Crohn's Disease Strictures.
    Clin Gastroenterol Hepatol. 2025 Sep 17:S1542-3565(25)00805.
    >> Share


    Dig Dis Sci

  3. JAMAL F, Odeh NB, Alatout MHI, Khan MA, et al
    Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
    Dig Dis Sci. 2025 Sep 22. doi: 10.1007/s10620-025-09387.
    >> Share

  4. BRONZE S, Shenoy S, Agrawal M, Polydorides AD, et al
    Prevalence and Clinical Features of Incidental Inflammatory Bowel Disease Identified During Screening and Surveillance Colonoscopy.
    Dig Dis Sci. 2025 Sep 19. doi: 10.1007/s10620-025-09400.
    >> Share

  5. GORE E, Femino C, Aronskyy I, Miller A, et al
    The Patient Experience with Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring: A Multicenter Study.
    Dig Dis Sci. 2025 Sep 18. doi: 10.1007/s10620-025-09390.
    >> Share


    Gastroenterology

  6. BOLTE LA, Bjork JR, Gacesa R, Weersma RK, et al
    Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy.
    Gastroenterology. 2025;169:813-827.
    >> Share

  7. VAN LIEROP LMA, Devillers MJC, van der Woude CJ, Hoentjen F, et al
    Long-term outcomes of increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission: 3-year follow-up of the randomized controlled LADI trial.
    Gastroenterology. 2025 Sep 19:S0016-5085(25)06024.
    >> Share

  8. IRWIN S, van Daelen M, Almaraz I, Park R, et al
    Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition.
    Gastroenterology. 2025;169:925-941.
    >> Share


    Inflamm Bowel Dis

  9. STENKE E, Alhassan D, Moclair M, Cooper S, et al
    Higher-Dose Infliximab Induction Achieves Better Maintenance Trough Levels in a National Pediatric IBD Cohort-A Retrospective Study.
    Inflamm Bowel Dis. 2025;31:2331-2337.
    >> Share

  10. AKASH H, Pandis N, Manschiebel W, Burisch J, et al
    A Systematic Review and Meta-Analysis of Animal Models on the Possible Link Between Periodontitis and Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2025;31:2561-2583.
    >> Share

  11. VERMEER E, Prins FM, Hidding IJ, Jagt JZ, et al
    Metagenomic Sequencing Reveals Distinct Gut Microbiome Profiles in Therapy-Naive de Novo Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Sep 12:izaf184. doi: 10.1093.
    >> Share

  12. JAIRATH V, Adsul S, Allocca M, Danese S, et al
    Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges.
    Inflamm Bowel Dis. 2025 Sep 15:izaf196. doi: 10.1093.
    >> Share

  13. FROST S, Ambastha C, Patel D, Roney A, et al
    Incidence of Anti-Drug Antibody Development in Older Adults with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Inhibitors: A Large Multicenter Cohort Study.
    Inflamm Bowel Dis. 2025 Sep 15:izaf170. doi: 10.1093.
    >> Share

  14. CHEN Q, McNinch C, May E, LaPoint P, et al
    Distinct Retrotransposon Transcriptome in Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2025 Sep 15:izaf190. doi: 10.1093.
    >> Share

  15. SCHREIBER S, Lee SD, van der Woude CJ, Marin-Jimenez I, et al
    Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2025 Sep 15:izaf163. doi: 10.1093.
    >> Share

  16. FUCHTBAUER JD, Brovkina O, Sivickis K, Aalykke C, et al
    Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies.
    Inflamm Bowel Dis. 2025 Sep 24:izaf217. doi: 10.1093.
    >> Share

  17. TEIGEN L
    Deciphering Mechanisms Underlying Success of Microbiome-Targeted Diet Therapy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2025 Sep 23:izaf203. doi: 10.1093.
    >> Share

  18. INNOCENTI T, Rocco C, Scarallo L, Lionetti P, et al
    Systematic Review of Available Intestinal Ultrasound Scores for Inflammatory Bowel Disease and Update on Validation Studies.
    Inflamm Bowel Dis. 2025 Sep 20:izaf183. doi: 10.1093.
    >> Share

  19. SINOPOULOU V, Gordon M, Liu S, Albuquerque DAN, et al
    Immunomodulators and Advanced Therapies for Induction of Remission in Crohn's Disease: A Systematic Review and Network Meta-Analysis.
    Inflamm Bowel Dis. 2025 Sep 19:izaf191. doi: 10.1093.
    >> Share

  20. BAEKGAARD FRW, Kjaer MD, Moller S, Hovvang SW, et al
    The Severity of Rectal Inflammation and Pouch Surgery Outcome in Patients with Ulcerative Colitis: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2025 Sep 16:izaf194. doi: 10.1093.
    >> Share

  21. SHEHAB M, Alrashed O, Alrashed F, Alyousefi R, et al
    Comparative Efficacy of Medical Therapies in Reducing the Risk of Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-Analysis.
    Inflamm Bowel Dis. 2025 Sep 18:izaf186. doi: 10.1093.
    >> Share

  22. TAN EX, An V, Garg M
    Diverting Loop Ileostomy as an Alternative to Emergent Colectomy in Acute Severe Ulcerative Colitis Flare following Checkpoint-Inhibitor Therapy.
    Inflamm Bowel Dis. 2025 Sep 19:izaf187. doi: 10.1093.
    >> Share

  23. OH SH, Rajendra C
    Capsule Endoscopy in Very Early-Onset Inflammatory Bowel Disease: Supporting the Clinician's Role in Disease Interpretation.
    Inflamm Bowel Dis. 2025 Sep 18:izaf165. doi: 10.1093.
    >> Share

  24. DRUGG HAHN G, Lakatos PL, Maedler-Kron C, Marcus V, et al
    Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2025 Sep 19:izaf008. doi: 10.1093.
    >> Share


    J Clin Gastroenterol

  25. TANRIVERDI LH, Aksan F, Aroniadis O, Monzur F, et al
    S1P Receptor Modulators Improve Clinical Outcomes in Ulcerative Colitis: A Stratified Meta-Analysis By Prior Biological Use, Corticosteroid Exposure, and Disease Characteristics.
    J Clin Gastroenterol. 2025 Sep 23. doi: 10.1097/MCG.0000000000002250.
    >> Share

  26. NARDELLI MJ, Cancado GGL, Barros LL, Dotta DD, et al
    Clinical and Prognostic Factors Associated With Inflammatory Bowel Disease in a Highly Admixed Population With Primary Sclerosing Cholangitis.
    J Clin Gastroenterol. 2025 Sep 24. doi: 10.1097/MCG.0000000000002253.
    >> Share


    J Crohns Colitis

  27. FAGGIANI I, Bencardino S, Peyrin-Biroulet L
    Catching fibrosis in motion: time-dependent diffusion MRI-derived cell diameter reveals the transitional state of intestinal scarring in Crohn's disease.
    J Crohns Colitis. 2025;19:jjaf146.
    >> Share


  28. Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study.
    J Crohns Colitis. 2025;19:jjaf123.
    >> Share

  29. BRAND EC, Roosenboom B, Lutter L, Malvar Fernandez B, et al
    Mucosal Kinase Activity and Inflammatory Profiles in Inflammatory Bowel Disease, and in Relation with Tofacitinib Response.
    J Crohns Colitis. 2025 Sep 23:jjaf174. doi: 10.1093.
    >> Share

  30. HILLEY P, Chin S, Wong D, De Cruz P, et al
    Implementation of Values based healthcare in inflammatory bowel disease-a review article.
    J Crohns Colitis. 2025 Sep 19:jjaf173. doi: 10.1093.
    >> Share

  31. COLWILL M, Povlsen S, Pollok R, Patel K, et al
    Glucagon-Like Peptide (GLP-1) Receptor Agonists in Inflammatory Bowel Disease: Mechanisms, Clinical Implications, and Therapeutic Potential.
    J Crohns Colitis. 2025 Sep 16:jjaf167. doi: 10.1093.
    >> Share

  32. ROTEM-TRYFUS O, Kang B, Orlanski-Meyer E, Ledder O, et al
    Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn's disease: a systematic review and prospective cohort study.
    J Crohns Colitis. 2025 Sep 19:jjaf172. doi: 10.1093.
    >> Share

  33. LEGA S, Dipasquale V, D'arcangelo G, Scarallo L, et al
    Real-Life Durability and Risk Factors for Biologic Discontinuation in Pediatric Inflammatory Bowel Disease: Results from the Sigenp IBD Registry.
    J Crohns Colitis. 2025 Sep 19:jjaf164. doi: 10.1093.
    >> Share

  34. MASSIMINO L, Solitano V, Ungaro F
    Repurposing losartan for fibrostenosing Crohn's disease: a compelling preclinical rationale.
    J Crohns Colitis. 2025;19:jjaf147.
    >> Share

  35. RAJA SS, Costello SP, Rayner CK, Day A, et al
    Examining the role of faecal microbiota transplantation for inducing remission in resistant ulcerative proctitis and distal ulcerative colitis (up-FMT).
    J Crohns Colitis. 2025 Sep 18:jjaf169. doi: 10.1093.
    >> Share

  36. ALLOCCA M, Jairath V, Sands BE, Rubin DT, et al
    International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.
    J Crohns Colitis. 2025 Sep 18:jjaf170. doi: 10.1093.
    >> Share


    J Gastroenterol

  37. MATSUOKA K, Hirai F, Watanabe K, Hokari R, et al
    Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study).
    J Gastroenterol. 2025 Sep 22. doi: 10.1007/s00535-025-02299.
    >> Share


    PLoS One

  38. CAI B, Qin X, Huang X, He X, et al
    Molecular mechanisms of dragon's blood in treating ulcerative colitis based on NF-kappab/NLPR3/Caspase-1 pyroptosis signaling pathway.
    PLoS One. 2025;20:e0331570.
    >> Share

  39. XIA P, Deng F, Liu D
    Development and validation of a machine learning-based predictive model for clinical remission in Crohn's disease patients receiving Adalimumab therapy.
    PLoS One. 2025;20:e0331447.
    >> Share


    Proc Natl Acad Sci U S A

  40. CHEN X, Hwang HS, Li B, Zhao Y, et al
    Nuclear receptor coregulator NRIP1 R448G modulates T cell gut homing to control intestinal inflammation.
    Proc Natl Acad Sci U S A. 2025;122:e2508269122.
    >> Share


    Scand J Gastroenterol

  41. YE C, Li W, Li X, Jiang Q, et al
    Risk factors for mucosal cytomegalovirus infection and specific endoscopic features in patients with ulcerative colitis.
    Scand J Gastroenterol. 2025 Sep 19:1-11. doi: 10.1080/00365521.2025.2558970.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016